Novartis Investigative Site

Moldava nad Bodvou 045 01

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Heart Failure With Preserved Ejection Fraction

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients — Completed